Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Uveitis and Ocular Immunology
How do you manage checkpoint inhibitor-associated Vogt-Koyanagi-Harada (VKH) disease in patients who have poorly controlled diabetes?
Related Questions
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How do you approach the management of bilateral non-infectious uveitis in the pediatric population?
How do you decide between steroids alone versus corticosteroids plus csDMARD for non-anterior sarcoid uveitis?
How do you differentiate between ocular involvement due to active tuberculosis versus latent infection in a patient with uveitis and suspected tuberculosis?
How do you decide on when to start or continue anti-VEGF injections during pregnancy?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
What is your preferred regimen for treating recalcitrant and recurrent macula-threatening ocular toxoplasmosis?
How would you approach the management of posterior uveitis caused by Toxoplasma gondii in immunocompromised patients, considering the potential for atypical presentations and treatment resistance?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
